AltheaDx Finds $27M In New Funding

San Diego-based AltheaDx, which is developing molecular diagnostics technology for the personalized medicine market, has raised $27M in its Series D funding round. Source of the new funding was not announced by the company. AltheaDx said the funding will go towards expanding its sales force and scaling up marketing efforts. AltheaDx is led by President and CEO Jorge Garces.